A client has been diagnosed with allergic rhinitis. Which symptoms would the nurse expect to observe?

(Select All that Apply.)

A) Take albuterol first.
Taking albuterol before salmeterol does not address the potential interaction between the two medications. It is important to avoid taking them together rather than just adjusting the order of administration.

B) The order of administration does not matter.
The order of administration does matter when it comes to medications with potential interactions. In this case, both albuterol and salmeterol are bronchodilators, and taking them together can increase the risk of adverse effects.

C) Take salmeterol first.
Similar to taking albuterol first, taking salmeterol before albuterol does not address the potential interaction between the two medications. The priority is to avoid taking them together unless specifically directed by the healthcare provider.

D) They should not be taken together.
Albuterol and salmeterol are both bronchodilators used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Albuterol is a short-acting beta agonist (SABA), typically used for quick relief of acute bronchoconstriction, while salmeterol is a long-acting beta agonist (LABA), used for long-term control and prevention of bronchospasm. Taking both medications together can increase the risk of side effects, including excessive stimulation of the beta receptors and potential cardiovascular effects. Therefore, it is important to follow healthcare provider's instructions and avoid taking albuterol and salmeterol together unless specifically directed to do so.

A. The medication will relieve wheezing: Albuterol is a short-acting beta agonist bronchodilator that works by quickly relaxing the smooth muscles of the airways, leading to rapid bronchodilation. This helps relieve symptoms such as wheezing, shortness of breath, and chest tightness commonly associated with asthma exacerbations.

B. The medication will reduce inflammation: Albuterol is not primarily indicated for reducing inflammation in asthma. While it can help alleviate symptoms of bronchospasm, it does not target the underlying inflammation associated with asthma.

C. The medication will increase the amount of mucus: Albuterol does not increase mucus production. In fact, it is a bronchodilator medication that primarily targets airway smooth muscle relaxation and bronchodilation to improve airflow and relieve symptoms.

D. The medication will decrease coughing episodes: Albuterol can help decrease coughing episodes by relieving bronchospasm and improving airflow. However, its primary mechanism of action is bronchodilation rather than directly targeting coughing.

E. The medication will open the airways: Albuterol works by stimulating beta-2 adrenergic receptors in the airway smooth muscles, resulting in relaxation of these muscles and dilation of the bronchial tubes. This action helps to open the airways, allowing for improved airflow and easier breathing.